Related Experiment Videos
Effects of beta-casomorphin on 3H-ouabain binding to guinea pig heart membranes
Die Pharmazie
|September 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improved Limit on the Effective Electron Neutrino Mass with the ECHo-1k Experiment.
Physical review letters·2026
First report of ceftazidime-avibactam resistance in non-mutated blaKPC-3 K. pneumoniae recovered from patients with no prior treatment, in Latin America.
Diagnostic microbiology and infectious disease·2025
Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
GA Eases Atherosclerosis by Regulating Circadian Rhythm.
Die Pharmazie·2026
A Systematic Intracranial Exposure-Response Evaluation of Brain-Penetrant Inhibitors: Informing Dose Selection for Brain Metastases.
Clinical and translational science·2026
Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
Journal of cardiovascular pharmacology·2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Analytical methods : advancing methods and applications·2026
Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment.
Chemical communications (Cambridge, England)·2026
Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics.
Drug development and industrial pharmacy·2026